[ad_1]
Genemod, a Seattle startup developing a cloud-based platform to help life sciences companies and researchers manage their data and workflows, raised $4.5 million.
The company sells collaborative workspace software that centralizes and structures research data, allowing real-time updates and remote collaboration. Users can track progress, visualize data, and see who made changes. The idea is to become the go-to standard for research scientists, like Figma for designers or Jira for engineers.
“The data shows that research teams and companies employing digital solutions for data and operations management outperform those relying solely on pen and paper,” CEO and co-founder Jacob Lee told GeekWire via email.
Lee is a former Juno Therapeutics engineer in technology strategy and innovation. He is joined by CTO and co-founder Jin Choe, a former software engineer at General Atomics Aeronautical Systems. Both founders are University of Washington graduates.
Genemod aims to tackle challenges with reproducibility, or the ability for researchers to recreate an experiment to achieve the same results. The pandemic accelerated the company’s adoption, with customers including AstraZeneca, Bristol-Myers, Merck, Fred Hutchinson Cancer Research Center, and others.
The fresh cash will go toward expanding its workforce and scaling its go-to-market operations. Genemod raised $1.7 million in October 2020. Total funding to date is $6.2 million. The latest round was co-led by existing investor Defy.vc and LDV Partners, with participation from Dolby Family Ventures and Cercano Ventures.
[ad_2]
Source link
